Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2008 / Cilt: 16 - Sayı: 3

Have drug-eluting stents changed the management of coronary artery disease in diabetic patients?

İlaç salınımlı stentler diyabetik hastalarda koroner arter hastalığının tedavisini değiştirdi mi?

Pages
198–204
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, in real life practice, bypass surgery is still more convenient for the majority of diabetic patients due to lesion characteristics and better long-term results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic coronary artery disease is characterized by diffuse multivessel disease, small coronary arteries, and progressive nature.
📊
Key Findings & Data:This type of coronary artery disease is also associated with high rates of restenosis compared to nondiabetic coronary artery disease.
💡
Conclusion & Impact:However, in real life practice, bypass surgery is still more convenient for the majority of diabetic patients due to lesion characteristics and better long-term results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic coronary artery disease is characterized by diffuse multivessel disease, small coronary arteries, and progressive nature. This type of coronary artery disease is also associated with high rates of restenosis compared to nondiabetic coronary artery disease. During the past five years drugeluting stents have provided promising results for preventing restenosis, which is currently the most important problem of percutaneous coronary interventions. However, in real life practice, bypass surgery is still more convenient for the majority of diabetic patients due to lesion characteristics and better long-term results.

Özet

Diyabetik koroner arter hastalığı diffüz ve çok sayıda damar tutulumu, ince damar yapısı ve ilerleyici olması ile karakterizedir. Bu tip koroner arter hastalığında, diyabetik olmayan koroner arter hastalığı ile karşılaştırıldığında yeniden daralma oranları yüksektir. Son beş yılda ilaç salınımlı stentler perkütan koroner girişimlerin en önemli sorunu olan yeniden darlık konusunda oldukça umut verici sonuçlar elde edilmesini sağlamıştır. Bu bulgulara karşın, gerçek hayatta birçok diyabetik hasta, lezyon özellikleri ve iyi uzun dönem sonuçlar nedeniyle hala bypassa daha uygundur.

🔖

Cite This Article

ÖKMEN, E. (2022). Have drug-eluting stents changed the management of coronary artery disease in diabetic patients?. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 16 - Sayı: 3, 198–204. https://ajindex.com/articles/425068

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Sicree R, Shaw JE, Zimmet PZ. The global burden of diabetes. In: Gan D, editor. Diabetes atlas. 2nd ed. Brussels: International Diabetes Federation; 2003. p. 15-71
  2. Mak KH, Faxon DP. Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 2003; 24:1087-103
  3. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-9
  4. Chaour M, Theroux P, Gilfix BM, Campeau L, Lesperance J, Ghitescu M, et al. ‘True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease. Coron Artery Dis 1997;8:683-8
  5. Melidonis A, Dimopoulos V, Lempidakis E, Hatzissavas J, Kouvaras G, Stefanidis A, et al. Angiographic study of coronary artery disease in diabetic patients in comparison with nondiabetic patients. Angiology 1999;50:997-1006
  6. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000;43:632-41
  7. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980;69:498-506
  8. Abaci A, Oğuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-42
  9. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron- beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001;21:2051-8
  10. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device specific analysis of 7147 patients. Circulation 2001;104:642-7
  11. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, et al. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005;45:198-203